The Potential Effect of Using the Cockcroft-Gault Method on Tenofovir-Associated Renal Impairment Reports and on Clinical Decisions Regarding Tenofovir Use in Individual Patients: Implications for the Future

Francis Kalemeera¹, Marike Cockeran², Mwangana Mubita¹, Dan Kibuule¹, Ester Naikaku¹, Amos Massele³ and Brian Godman^4,5,6*

¹School of Pharmacy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia

²Medicine Usage in South Africa (MUSA), Faculty of Health Sciences, North West University, Potchefstrom, South Africa

³Department of Clinical Pharmacology, School of Medicine, University of Botswana, Gaborone, Botswana

⁴Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University, Sweden

⁵Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom

⁶Health Economics Centre, University of Liverpool Management School, Liverpool, UK

^*Corresponding Author: Brian Godman, Department of Laboratory Medicine, Division of Clinical Pharmacology Karolinska Institutet, Karolinska University, Sweden, Tel: + 46 8 58581068, Fax: + 46 8 59581070 Email: